PIK3CB and neoplasm: Pre-clinical data indicated that some PTEN-deficient neoplasms, including PCa, activated the PI3K pathway via the p110beta isoform of the PI3K catalytic subunit (Jia et al., 2008; Wee et al., 2008; Ni et al., 2012).